AfterPullback: Biotech Stocks

AfterPullback: Biotech Stocks

“AfterPullback: Biotech Stocks” delivers a comprehensive overview of leading U.S.-traded biotech companies, along with emerging and innovative firms that have recently entered the public market. Our selection spans a variety of sectors within biotech, including gene editing, diagnostics, pharmaceuticals, immunotherapy, cancer treatment, regenerative medicine, and bioinformatics.

6 Symbols in watchlist.
SymbolPriceChange %Market CapVolume
MRNA $33.32 -1.45% $14.18B 6,295,489
PACB $1.13 -4.24% $351.47M 5,764,127
BNTX $90.29 -0.85% $22.79B 1,140,687
FLGT $17.31 2.43% $520.09M 524,655
CRSP $33.14 -2.62% $3.17B 2,111,066
ILMN $79.34 -0.83% $12.67B 1,744,142

Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.